Bender Robert & Associates
- SEC CIK
- 0000894300
- Latest filing
- Jul 30, 2026
MRK holding history
Merck & Co., Inc. in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRK overviewAll 13F holders of MRKFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,042
- Value
- $519.4K
- % of portfolio
- 0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,042 | $519.4K | 0.1% | −35−0.9% | Reduced | Holders |
| Q1 2026 | 4,077 | $490.4K | 0.1% | −360−8.1% | Reduced | Holders |
| Q4 2025 | 4,437 | $467.0K | 0.1% | −375−7.8% | Reduced | Holders |
| Q3 2025 | 4,812 | $403.9K | 0.1% | −100−2.0% | Reduced | Holders |
| Q2 2025 | 4,912 | $388.8K | 0.1% | −20−0.4% | Reduced | Holders |
| Q1 2025 | 4,932 | $442.7K | 0.1% | −50−1.0% | Reduced | Holders |
| Q4 2024 | 4,982 | $495.6K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 4,982 | $565.7K | 0.1% | +4,982 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −6,663−100.0% | Sold out | Holders |
| Q1 2024 | 6,663 | $879.2K | 0.2% | −60−0.9% | Reduced | Holders |
| Q4 2023 | 6,723 | $732.9K | 0.2% | −243−3.5% | Reduced | Holders |
| Q3 2023 | 6,966 | $717.1K | 0.2% | −550−7.3% | Reduced | Holders |
| Q2 2023 | 7,516 | $867.3K | 0.2% | −936−11.1% | Reduced | Holders |
| Q1 2023 | 8,452 | $899.2K | 0.3% | −140−1.6% | Reduced | Holders |
| Q4 2022 | 8,592 | $953.3K | 0.4% | 00.0% | Unchanged | Holders |
| Q3 2022 | 8,592 | $740.0K | 0.3% | +880+11.4% | Added | Holders |
| Q2 2022 | 7,712 | $703.0K | 0.3% | 00.0% | Unchanged | Holders |
| Q1 2022 | 7,712 | $633.0K | 0.2% | +1,270+19.7% | Added | Holders |
| Q4 2021 | 6,442 | $484.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 6,442 | $484.0K | 0.1% | +50+0.8% | Added | Holders |
| Q2 2021 | 6,392 | $497.0K | 0.1% | +90+1.4% | Added | Holders |
| Q1 2021 | 6,302 | $486.0K | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.